TRV-2026-1071Version 1 · Certified
Reason for this version
Certified into the record
Canonical text (the exact bytes fingerprinted)
TRUVACE RECORD VERSION record: TRV-2026-1071 version: 1 kind: certified reason: Certified into the record timestamp: 2026-09-13T06:56:48.701462Z status: published lens: trace sector: health headline: Explainable machine learning for breast cancer prediction in resource-constrained settings: A multi-algorithmic framework integrating shap-based transparency with clinical decision support dek: Breast cancer remains the most commonly diagnosed malignancy among women globally, with disproportionately higher mortality rates in low- and middle-income countries (LMICs) where diagnostic delays and limited specialist pathology capacity are widespread. While machine learning (ML) approaches achieve strong predictive performance for cancer classification, algorithmic opacity and absence of interpretability frameworks tailored to resource-constrained environments have impeded clinical adoption. This study bridg… gain_title: Explainable ML models achieved near-perfect discrimination for breast cancer diagnosis on cytology data, with top models reaching 0.996 AUC and 98.25% accuracy, supporting use in resource-constrained diagnostic workflows. problem_title: Algorithmic opacity and lack of interpretability frameworks tailored to resource-constrained environments have impeded clinical adoption of ML for breast cancer, contributing to diagnostic delays in settings with limited pathology capacity. trace_subject: machine learning for breast cancer diagnosis in resource-constrained settings gain_reading: Explainable ML models achieved near-perfect discrimination for breast cancer diagnosis on cytology data, with top models reaching 0.996 AUC and 98.25% accuracy, supporting use in resource-constrained diagnostic workflows. gain_evidence: All ensemble and regularized models achieved test-set AUCs above 0.98, with XGBoost and SVM attaining the highest AUC of 0.996 | Logistic Regression the highest accuracy (98.25%) and MCC (0.962) problem_reading: Algorithmic opacity and lack of interpretability frameworks tailored to resource-constrained environments have impeded clinical adoption of ML for breast cancer, contributing to diagnostic delays in settings with limited pathology capacity. problem_evidence: algorithmic opacity and absence of interpretability frameworks tailored to resource-constrained environments have impeded clinical adoption | disproportionately higher mortality rates in low- and middle-income countries (LMICs) where diagnostic delays and limited specialist pathology capacity are widespread quick_read: On September 11, 2026, a peer-reviewed study in PLOS Digital Health reported an explainable AI framework for breast cancer diagnosis designed for underserved settings. Using 569 fine-needle aspirate specimens from the Wisconsin dataset, the authors benchmarked eight supervised classifiers with 10-fold cross-validation and a hold-out test set, then applied SHAP analysis to surface global and individual-level feature contributions. The work matters because high predictive scores alone have not translated into clinical use where specialist pathology is scarce and mortality is higher. By pairing strong discrimination and calibration results with transparent feature rankings that match cytopathological knowledge, the study offers a reproducible template for equitable deployment, though its evidence remains limited to a single curated dataset rather than prospective implementation in LMIC clinics. limitation: tag: Dual reading key_points: Study used Wisconsin Breast Cancer Diagnostic Dataset with 569 fine-needle aspirate specimens and 30 nuclear morphometric features. | Benchmarked eight algorithms with stratified 10-fold cross-validation and 80:20 hold-out test split, evaluating AUC-ROC, F1-score, MCC, and Brier score. | SHAP analysis identified worst perimeter, worst concave points, and worst area as dominant predictors with strong cross-model concordance. | Logistic Regression showed superior probability calibration, noted as critical for clinical risk stratification in low-resource settings. rundown: Researchers evaluated Logistic Regression, Random Forest, XGBoost, LightGBM, SVM, Gradient Boosting, Decision Tree, and K-Nearest Neighbors on 569 specimens, reporting ensemble and regularized models above 0.98 AUC and pairwise SHAP ranking correlations up to 0.86 between XGBoost and LightGBM. Interpretability was operationalized through SHAP global importance, cross-model consensus ranking, and individual-level dependence characterization, with authors stating SHAP-derived signatures align with established cytopathological principles to support responsible integration into resource-limited workflows. sources: - peer_reviewed | PLOS Digital Health | https://doi.org/10.1371/journal.pdig.0001706 | 2026-09-11 prev: 0000000000000000000000000000000000000000000000000000000000000000
- sha256
- 937490ee99b6b5d6de3b2a485ffa2c98e6ee3a3909b29255a1de724ef4e624a8
- previous
- 0000000000000000000000000000000000000000000000000000000000000000
Verify this record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-1071 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.
ace